Conference Presentations

2011


ICOSR (Workshop)

Can Improved Signal Detection in International Schizophrenia Trials Be Attained with Blinded Independent Calibrated Raters? 13th International Congress On Schizophrenia Research (April 2011) Williams, J.B.W. VIEW PRESENTATION

2009


Sources of Unreliability in Depression Ratings. American Psychological Association (August 2009). Kobak, K.A., Brown, B., Sharp, I.R., Levy-Mack, H., Wells, K., Ockun, F., Williams, J.B.W.

NCDEU (Panel)

Innovative Responses to Critical Path Initiatives in Psychiatric Drug Trials. New Clinical Drug Evaluation Unit (June 2009). Laughren, L., Williams, J.B.W. Reines, S., Fava, M.


2008


CNS (Workshop)

The High & Growing Rate of Failed CNS Trials: Causes and an FDA Supported Solution. Partnering, Licensing & Deal-Making Summit (December 2008). Gilbert, P.

The Use of Remote Centralized Raters via Live Two-Way Video in a Multicenter Clinical Trial for Schizophrenia. New Clinical Drug Evaluation Unit (June 2008). Shen, J., Kobak, K.A., Zhao, Y., Alexander, M., Kane, J.
 

2007


Face-to-face vs. Remote Administration of the Montgomery-Asberg Depression Rating Scale (MADRS) using Videoconference and Telephone. New Clinical Drug Evaluation Unit (June 2007). Kobak, K.A., Williams, J.B.W.

A Pilot Study of Video Telemedicine in the Assessment of Primary Care Patients with Anxiety and Depressive Disorders. The Depression Inventory Development (DID) Team: A Progress Report. New Clinical Drug Evaluation Unit (June 2007). Williams, J.B.W., Ellis, A., Middleton, A., Kobak, K.A.

NCDEU (Presentation)

Novel Approaches to improving Quality of Clinical Trials Rating Data. New Clinical Drug Evaluation Unit (June 2007). Kane, J., Kobak, K.A., Williams, J.B.W.

Global CNS Drugs Summit (Presentation)

Is There a Way to Stop Clinical Trials Failing and Could Centralized Ratings of Symptoms Be a Solution? Global CNS Drugs Summit (May 2007). Giller, E.

APA (Workshop)

Challenging the Status Quo: Centralized Assessments in Psychiatric Clinical Trials. American Psychiatric Association (May 2007). Fava, M., Williams, J.B.W., Leon, A., Grebb, J., Potter, W.Z. Kane, J.

ISCTM (Presentations)

The Use of Centralized Raters in Multi-Center Clinical Trials for Schizophrenia. International Society for CNS Clinical Trials and Methodology (February 2007). Kane, J., Schmidt, J., Kobak, K.A.

Improving Inter-Rater Reliability in Clinical Trials: Development and Validation of a Structured Interview Guide for the Montgomery-Asberg Depression Rating Scale (SIGMA). International Society for CNS Clinical Trials and Methodology (February 2007). Williams, J.B.W, Kobak, K.A.

2006


CINP (Workshop)

The Challenge of Outcome Assessment in Psychiatric Clinical Trials. Clinical Trials Workshop, Collegium Internationale Neuro-Psychopharmacologicum (July 2006). Engelhardt, N.

NCDEU (Workshop)

New Uses for Old Technologies: Telepsychiatry and Biomarkers in Psychiatric Clinical Drug Trials.  New Clinical Drug Evaluation Unit (June 2006). Engelhardt, N., Hilty, D., Opler, M., Sweeney, J., Laughren, T., Kane, J.

ISCTM (Presentation)

Impact of Factors Associated with Clinician Ratings on Placebo Response and Signal Detection. International Society for CNS Clinical Trials and Methodology (February 2006). Kobak, K.A.

 

Key:

  • ACNP  American College of Neuropsychopharmacology
  • CINP  Collegium Internationale Neuro-Psychopharmacologicum
  • ISCTM  International Society for CNS Clinical Trials and Methodology
  • DIA Drug Information Association
  • NCDEU  New Clinical Drug Evaluation Unit
  • ICOSR International Congress of Schizophrenia Research
  • ATA American Telemedicine Association
  • APA American Psychiatric Association
  • APA American Psychological Association